Press Releases Cyclopharm Limited

Equities

Delayed Australian S.E. Other stock markets 11:29:31 09/05/2024 am IST			5-day change	1st Jan Change
1.71 ^AUD	-4.74%		-2.29%	-11.17%

19/03	Cyclopharm's Technegas Device Carries Out Imaging of First US Patients	MT
18/03	Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index	CI

Cyclopharm : CYC Investor Presentation 24 May 2022	24/22/24	PU
Bell Potter HealthCare Conference	09/21/09	PU
Cyclopharm : 21-Dec-2017 – FNN INTERVIEW AND PRESENTATION (353KB)	21/17/21	PU
Cyclopharm : 20-Nov-2017 – Change of Director’s Interest Notice (594.97KB)	20/17/20	PU
Cyclopharm : 18-Oct-2017 – Cyclopharm CEO Presentation at Australian MicroCap Conference (678.12KB)	18/17/18	PU
Cyclopharm : Technegas USFDA Clinical Trial - Patient Enrolment Underway	26/17/26	PU
Cyclopharm : acquires European distribution business	20/17/20	PU
Cyclopharm : 1H2017 Results Investor Presentation	12/17/12	PU
Cyclopharm : Form 484 - cancellation of Long Term Incentive Plan shares	08/17/08	PU
Cyclopharm : Dividend/Distribution - CYC	28/17/28	PU
Cyclopharm : Nuclear imaging trial aiming to clear up airway diagnosis	18/17/18	PU
Cyclopharm : CYC CEO To Present at Bioshares 2017 Biotech Conference	21/17/21	PU
Cyclopharm : Change in substantial holding - Barings Acceptance Limited	06/17/06	PU
Cyclopharm : Change in substantial holding from CVC	06/17/06	PU
Cyclopharm : Change in substantial holding from AEF	06/17/06	PU
Cyclopharm : Change of Director's Interest Notice - JMcBrayer	06/17/06	PU
Cyclopharm : Change of Director's Interest Notice - VGould	06/17/06	PU
Cyclopharm : Change of Director's Interest Notice - D Heaney	06/17/06	PU
Cyclopharm : Appendix 3B Final	06/17/06	PU
Cyclopharm : CYC Entitlement Offer Closed	06/17/06	PU

No results for this search